Apollo Hospitals Arm Buys 11.2% Stake in Keimed for ₹625.23 Crore

Apollo Healthco Limited (AHL), a crucial arm of Apollo Hospitals Enterprise Limited, has successfully concluded its acquisition of a stake in Keimed Private Limited. This strategic move is expected to strengthen Apollo’s presence in the healthcare distribution sector.

Overview of the Transaction  

Apollo Healthco Limited (AHL), a significant subsidiary of Apollo Hospitals Enterprise Limited (the Company), has completed the acquisition of shares in Keimed Private Limited. This transaction was carried out in two parts as outlined in the agreement dated April 26, 2024. The deal involved purchasing shares from Ms Shobana Kamineni, a promoter and related party of AHL and making a primary investment in Keimed.

Details of the Acquisition  

AHL acquired a total of 11.2% of Keimed’s issued and paid-up share capital on a fully diluted basis. The transaction was split into two tranches:  

• The purchase of shares from Ms. Shobana Kamineni amounted to  ₹625.43 crores.  
• A primary investment of ₹99.99 crores was made by AHL into Keimed.  

About Apollo Hospitals 

Apollo Hospitals, founded by Dr. Prathap C Reddy in 1983, is a leading healthcare network in India known for its extensive services, including routine wellness, advanced treatments and diagnostic care. With over 73 hospitals, 5,000 pharmacies, and 1,100 diagnostic centers, Apollo serves patients globally and has impacted over 200 million lives from 120+ countries. Headquartered in Chennai, it is recognized for its quality standards, international accreditation and strong financial performance.

Share performance 

As of March 24, 2025, at 2:05 PM, the Apollo Hospitals Enterprise share price is trading at ₹6,650 per share, reflecting a surge of 0.58% from the previous day’s closing price. Over the past month, the stock has registered a profit of 6.38%. The stock’s 52-week high stands at ₹7,545.35 per share, while its low is ₹5,693.20 per share.

Conclusion

Apollo Healthco’s acquisition of a stake in Keimed strengthens its position in the healthcare distribution market, reflecting its commitment to growth and expansion.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.